Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy
Clinical trial NCT02638207 · COMPLETED
Trial details
- NCT number
- NCT02638207
- Sponsor
- Octapharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-27
- Primary completion
- 2019-09-05
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.